| 期 |
栏目 |
标题 |
文件 |
| 卷 32, 编号 7 (2021) |
Articles |
Osteoporosis in elderly patients: prevalence, pathogenesis, clinical presentations, prevention of complications |
|
| 卷 32, 编号 8 (2021) |
Articles |
Impact of aorto-coronary bypass surgery on quality of life and prognosis in patients with coronary heart disease |
|
| 卷 32, 编号 9 (2021) |
Articles |
OSTEOPOROSIS IN PATIENTS OF DIFFERENT AGE GROUPS: CLINICAL AND PATHOGENETIC ASPECTS AND TREATMENT WITH THE USE OF OSTEOMED, OSTEO-VIT D3 AND OSTEOMED FORTE DRUGS |
|
| 卷 32, 编号 10 (2021) |
Articles |
Comparison of the effectiveness of Osteomed, Osteomed Forte and Osteo-Vit D3 in the prevention of osteoporotic fractures of various localization |
|
| 卷 32, 编号 12 (2021) |
Articles |
The use of Osteomed, Osteomed Forte, and Osteo-Vit D3 in patients with osteoporosis: combination treatment for and prevention of fractures |
|
| 卷 33, 编号 1 (2022) |
Articles |
Osteoporosis in postmenopausal women: sociomedical significance, prevention of fractures with Osteomed and Osteomed Forte |
|
| 卷 33, 编号 2 (2022) |
Articles |
New coronavirus infection: clinical and pathogenetic aspects, prevention, importance of vitamins and trace elements |
|
| 卷 33, 编号 4 (2022) |
Articles |
Novel coronavirus infection: selenium, selenium-containing drugs, prevention of complications |
|
| 卷 33, 编号 3 (2022) |
Articles |
BIOCHAGA IS A SUBLIMATED BIRCH FUNGUS CHAGA EXTRACT WITH PROVEN ANTITUMOR AND IMMUNOMODULATORY EFFECTS, WHICH IS PRODUCED ACCORDING TO THE AUTHOR’S UNIQUE TECHNOLOGY |
|
| 卷 33, 编号 5 (2022) |
From Practice |
Novel coronavirus infection (COVID-19): epidemiology, clinical characteristics of patients, risk of complications, prevention, use of selenium-containing drugs |
|
| 卷 33, 编号 10 (2022) |
Articles |
DIHYDROQUERCETIN: PHARMACOLOGICAL PROPERTIES, POSSIBILITY OF USING THE DRUG IN CLINICAL PRACTICE |
|
